Home
Conditions
Leukemia, Myeloid

Clinical trial condition

Leukemia, Myeloid

Explore clinical trials studying Leukemia, Myeloid. Study availability and eligibility vary by location and protocol.

3,102 public trials 617 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Myeloid trial results

Recruiting

ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies

NCT06656494

Conditions: Acute Myelogenous Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations: Yale University, Yale Cancer Center New Haven, Connecticut, United States

NYU Langone Health New York, United States

St Vincent's Hospital Sydney, New South Wales, Australia

Royal Perth Hospital Perth, Western Australia, Australia

View all 18 locations

View Trial Details

Recruiting

Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine Plus Venetoclax for the Treatment of Newly Diagnosed Monocytic AML and Active Signaling Mutated AML

NCT06504459

Conditions: Acute Monocytic Leukemia, Acute Myeloid Leukemia, Hematologic Diseases, +7 more
Locations: University of Miami Miller School of Medicine-Sylvester Cancer Center Miami, Florida, United States

OHSU Knight Cancer Institute Portland, Oregon, United States

View Trial Details

Recruiting

High-dose Ascorbate (HDA) in Combination With Standard of Care Azacitidine and Venetoclax in Acute Myeloid Leukemia (AML)

NCT07177079

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: University of Iowa Health Care Iowa City, Iowa, United States

View Trial Details

Recruiting

Study of BMS-986497 (ORM-6151) as a Monotherapy, in Double and Triple Combination With Azacitidine and Venetoclax in Participants With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome

NCT06419634

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations: Yale-New Haven Hospital New Haven, Connecticut, United States

Northwestern Memorial Hospital Chicago, Illinois, United States

Local Institution - 0007 Boston, Massachusetts, United States

Massachusetts General Hospital Boston, Massachusetts, United States

View all 16 locations

View Trial Details

Recruiting

Backtracking Leukemia-Typical Somatic Mutations in Cord Blood

NCT05014165

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Hematologic Diseases, +12 more
Locations: University of Minnesota/Masonic Cancer Center Minneapolis, Minnesota, United States

View Trial Details

Recruiting

Vyxeos for Re-induction Treatment of Acute Myeloid Leukemia Patients With Persistent Disease After Induction

NCT04049539

Conditions: Blasts More Than 5 Percent of Bone Marrow Nucleated Cells, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations: UC Davis Comprehensive Cancer Center Sacramento, California, United States

Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Recruiting

VA-CIG Regimen for Previously Untreated Acute Myeloid Leukemia: A Multicenter Prospective Single-Arm Trial

NCT07514832

Conditions: AML (Acute Myeloid Leukemia), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Chinese PLA General Hospital Beijing, China

View Trial Details

Recruiting

WearAble Technology for Collecting Health Data in People Who Are the Transfused (WATCH Transfused) - A UK Exploratory Study to Improve Quality of Life and the Efficacy of Transfusion Supportive Care in People With Blood Cancers Undergoing Treatment

NCT07511829

Conditions: AML (Acute Myeloid Leukemia), Anemia, Anemia, Refractory, +11 more
Locations: Oxford University Hospitals NHS Trust Oxford, OXFORDSHIRE, United Kingdom

View Trial Details

Recruiting

Venetoclax Combined With CACAG Regimen Versus "3+7" Regimen in the Treatment of Acute Monocytic Leukemia

NCT07512700

Conditions: Acute Monocytic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations: Air Force Medical Center, PLA Beijing, China

Chinese PLA General Hospital Beijing, China

PLA Strategic Support Force's Characteristic Medical Center Beijing, China

View Trial Details

Recruiting

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

NCT05735717

Conditions: AML, Acute Leukemia, Acute Lymphoblastic Leukemia, +74 more
Locations: University of Minnesota Masonic Cancer Center Minneapolis, Minnesota, United States

View Trial Details

Leukemia, Myeloid

Leukemia, Myeloid trial results

Related conditions